Federal Register notice: FDA makes available a guidance entitled Manufacturers Sharing Patient-Specific Information from Medical Devices with Patients...
FDA warns Indias Kim Chemicals about CGMP and other violations in its manufacturing of OTC products.
An FDA safety update says that interim study results from a pivotal clinical trial continue to show an increased rate of major adverse cardiac events ...
FDA warns Accelerated Analytical Laboratories about CGMP violations at its drug manufacturing facility.
FDA says it will recognize drug manufacturing inspections from eight European countries, avoiding duplication of inspections and resources.
As a condition of approval, FDA is requiring that AstraZeneca conduct additional studies to verify and describe anticipated clinical benefits of Calqu...
CDRH associate director Suzanne Schwartz says the agency works with medical device manufacturers to address cybersecurity issues.
Attorney Serra Schlanger says New Jersey is considering a proposal to restrict drug company payments and gifts to healthcare professionals with author...